John W. Puziss, Ph.D., leads the Business Development team at OCR, which is responsible for the commercialization of technologies invented at Yale University. This team of business development professionals evaluates the commercial potential and patentability of Yale technologies, develops commercialization strategies, and negotiates licenses and collaborative R&D agreements to maximize the potential of these technologies.
Prior to joining OCR, John was an associate at Proteome, Inc., a senior research investigator at Bristol-Myers Squibb and an American Cancer Society postdoctoral fellow at Johns Hopkins University School of Medicine.
He holds a B.S. (cum laude) from the University of Rochester and a Ph.D. in Microbiology and Immunology from the University of North Carolina-Chapel Hill School of Medicine.